Position Paper - Europabio

About us
- What we do
- Who we are
Members
- EuropaBio Members
- About Membership
How we work
Activities
News & Events
- News
- Events
Library

Become a member

07/07/2025

EuropaBio Position on the Critical Medicines Act
24/06/2025

EuropaBio recommendations for the Bioeconomy Strategy
24/06/2025

Joint industry definitions of fermentation and precision fermentation
18/06/2025

EuropaBio conclusions on Patient BioForum 2025
10/06/2025

EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union
04/06/2025

EuropaBio response to EC Call for evidence for an evaluation of “Apply AI Strategy – strengthening the AI continent”
16/04/2025

EuropaBio position on the EU Life Sciences Strategy
08/04/2025

EFIB 2025 Brussels Statement
24/03/2025

Response to the EC Call for Evidence for an evaluation of ”EU rules on medical devices and in vitro diagnostics”
18/03/2025

Response to the European Commission Call for Evidence for the EU Startup and Scaleup Strategy
07/03/2025

Response to the Call for Evidence on the evaluation of the Public Procurement Directives
26/02/2025

EuropaBio response to the Call for Evidence on the Critical Medicines Act
20/02/2025

Implementation of the Net-Zero Industry Act
09/02/2025

Boosting Attractiveness of the EU for ATMP Developers
31/01/2025

EuropaBio Response to the Commission Public Consultation on the Single Market Strategy 2025
20/01/2025

The EU Biotech Act – EuropaBio Vision Paper
05/12/2024

Joint Industry Statement on JSC capacity
19/07/2024

Microorganisms & industrial biotechnology: challenges and opportunities for Europe
18/07/2024

EuropaBio Congratulates Ursula von der Leyen on Re-election as COM President
04/07/2024

Joint Statement for an Ambitious FP10

1 2 3...5

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Extra links

Newsroom

Become a member

Media pack

Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.